Successful Fill & Finish / Containment webinar with Bausch+Ströbel

Containment Webinar with B+S

On September 11th Richard Denk from SKAN and Thomas Bühler from Bausch+Ströbel held an interesting webinar about Innovative Aseptic Processing of Antibody-Drug Conjugates.

With four antibody-drug conjugates (ADC) approved by the U.S. Food and Drug Administration (FDA), the development and manufacturing of targeted ADC therapies has become a booming field. Due to the intrinsic complexity of these drug entities, development and manufacturing of antibody-drug conjugates remains very challenging. Strict containment is required to guarantee the protection and safety of both operators and products.

Register here to watch: Webinar


Meet SKAN's specialists in person at trade fairs and conventions.

Learn More


Videos about products and interviews

Learn More

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.